SLC5A2 and heart failure: Moreover, in a small randomized controlled trial includingpatients with heart failure and reduced ejection fraction, sodium-glucosecotransporter 2 inhibitors (SGLT-2) in addition to other guideline directedmedical therapy for heart failure were found to be more effective in improving RVfunction as compared to other heart failure drugs alone [66].